查看文章

There is provided novel anticancer and antibacterial com pounds, pharmaceutically acceptable salts thereof, and pro cesses for their preparation. The compounds have anticancer activity, which results in the reduction of tumour cell pro liferation, enhances cancers cells apoptosis and regulation of iron signalling. The compounds are also particularly active against various Gram-negative and Gram-positive multi drug-resistant bacteria, such as extended-spectrum beta lactamase (ESBL) producing and colistin-resistant Escheri chia coli, carbapenem-resistant E. coli, carbapenem resistant Acinetobacter baumannii, and methicillin-resistant